| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adding stroke to the political agenda in Europe
|
The Lancet Neurology,
|
|
|
18 |
6 |
p. 513
|
article
|
| 2 |
A new step towards targeting tau
|
Corvol, Jean-Christophe
|
|
|
18 |
6 |
p. 517-518
|
article
|
| 3 |
Correction to Lancet Neurol 2019; 18: 504–12
|
|
|
|
18 |
6 |
p. e5
|
article
|
| 4 |
CSF and blood biomarkers for Parkinson's disease
|
Parnetti, Lucilla
|
|
|
18 |
6 |
p. 573-586
|
article
|
| 5 |
Dopamine for motor recovery after stroke: where to from here?
|
Stinear, Cathy M
|
|
|
18 |
6 |
p. 514-515
|
article
|
| 6 |
Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial
|
Toyoda, Kazunori
|
|
|
18 |
6 |
p. 539-548
|
article
|
| 7 |
Exploring memories of Rasputin, the Queen, and police interviews
|
Ranscombe, Peter
|
|
|
18 |
6 |
p. 529
|
article
|
| 8 |
First report the findings: genuine balance when reporting CTE
|
Finkel, Adam M
|
|
|
18 |
6 |
p. 521-522
|
article
|
| 9 |
First report the findings: genuine balance when reporting CTE
|
Casper, Stephen T
|
|
|
18 |
6 |
p. 522-523
|
article
|
| 10 |
IDEAS becoming reality on the roadmap for biomarker validation in Alzheimer's disease
|
Frisoni, Giovanni B
|
|
|
18 |
6 |
p. 519-520
|
article
|
| 11 |
Imaging biomarkers of vulnerable carotid plaques for stroke risk prediction and their potential clinical implications
|
Saba, Luca
|
|
|
18 |
6 |
p. 559-572
|
article
|
| 12 |
Introducing the International Women in Multiple Sclerosis network
|
Jokubaitis, Vilija G
|
|
|
18 |
6 |
p. 521
|
article
|
| 13 |
Luca Saba
|
|
|
|
18 |
6 |
p. 527
|
article
|
| 14 |
Meeting the neurological needs of refugees and other forcibly displaced people
|
Burton, Adrian
|
|
|
18 |
6 |
p. 524-525
|
article
|
| 15 |
Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial
|
Ford, Gary A
|
|
|
18 |
6 |
p. 530-538
|
article
|
| 16 |
Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial
|
Boxer, Adam L
|
|
|
18 |
6 |
p. 549-558
|
article
|
| 17 |
Stephen Waxman: pioneer in axons, their disorders, and pain
|
Kirby, Tony
|
|
|
18 |
6 |
p. 526
|
article
|
| 18 |
Stroke genetics: discovery, biology, and clinical applications
|
Dichgans, Martin
|
|
|
18 |
6 |
p. 587-599
|
article
|
| 19 |
The art of memory
|
Williamson, Jack
|
|
|
18 |
6 |
p. 527-528
|
article
|
| 20 |
Therapeutic interventions in patients with prolonged disorders of consciousness
|
Thibaut, Aurore
|
|
|
18 |
6 |
p. 600-614
|
article
|
| 21 |
The uncertain role for phosphodiesterase inhibitors in stroke prevention
|
Hill, Michael D
|
|
|
18 |
6 |
p. 515-517
|
article
|
Journal description